NSRX is trading at approximately $3.11 (6% down), pulling back as it gives back a portion of its recent rally leading into upcoming investor presentations.
- Nasus Pharma is scheduled to present at the Zacks Life Sciences Investor Forum on June 24–25, 2026, where management will be available for one-on-one meetings.
- The downward move appears to be driven by normal volatility and profit-taking following prior gains, as there have been no new clinical or financial disclosures to date.